Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

GABAergic steroid precursors reduce ethanol withdrawal symptoms in certain mice.

Divalproex sodium significantly improved headaches in two-thirds of patients.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Activating δ-opioid receptors can help hair grow.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Some drugs can cause serious side effects like heart issues and nervous system problems, but certain drugs for Parkinson's and overactive bladder may be safer, though they still have some common side effects.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

5alpha-DHP may be a safe, effective treatment for certain seizures without causing sedation.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

ATP helps prevent skin damage from vandetanib by reducing stress.

α-MSH increases melanin production in moulting hair follicles, while AVT inhibits it.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Lower allopregnanolone levels increase stress-related dopamine release in the brain.

Potassium channel openers like minoxidil boost hair growth.

Using GnRHa agonists helps diagnose and treat ovarian hyperthecosis when surgery isn't possible.

Cannabidivarin (CBDV) may help brain cell growth and survival through the TRPV1 receptor.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

OXTR agonists may promote hair growth and be effective for treating hair loss.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Neurosteroids help control dopamine responses in the brain.

Antiandrogens help improve developmental delays caused by valproic acid in rats.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.